Legal & General Group
SLDB icon

Legal & General Group’s Solid Biosciences SLDB Stock Holding History

Legal & General Group’s Portfolio SLDB Stock Details SLDB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$76.3K Buy
7,639
+2,369
+45% +$18K ﹤0.01% 2671
2026
Q1 		$37.9K Hold
5,270
– – ﹤0.01% 2749
2025
Q4 		$29.7K Hold
5,270
– – ﹤0.01% 2875
2025
Q3 		$32.5K Sell
5,270
-741
-12% -$4.33K ﹤0.01% 2851
2025
Q2 		$29.3K Buy
6,011
+4,063
+209% +$14.4K ﹤0.01% 2863
2025
Q1 		$7.21K Hold
1,948
– – ﹤0.01% 3229
2024
Q4 		$7.79K Hold
1,948
– – ﹤0.01% 3295
2024
Q3 		$13.6K Hold
1,948
– – ﹤0.01% 3196
2024
Q2 		$11K Buy
+1,948
New +$17.4K ﹤0.01% 3279
2022
Q2 		– Sell
-317
Closed -$6K – 3641
2022
Q1 		$6K Hold
317
– – ﹤0.01% 3492
2021
Q4 		$8K Hold
317
– – ﹤0.01% 3500
2021
Q3 		$11K Hold
317
– – ﹤0.01% 3434
2021
Q2 		$17K Buy
317
+145
+84% +$9.58K ﹤0.01% 3351
2021
Q1 		$14K Buy
172
+28
+19% +$3.1K ﹤0.01% 3285
2020
Q4 		$16K Hold
144
– – ﹤0.01% 3178
2020
Q3 		$4K Sell
144
-81
-36% -$3.1K ﹤0.01% 3394
2020
Q2 		$10K Buy
225
+43
+24% +$1.78K ﹤0.01% 3312
2020
Q1 		$7K Sell
182
-71
-28% -$3.51K ﹤0.01% 3224
2019
Q4 		$17K Buy
253
+8
+3% +$883 ﹤0.01% 3223
2019
Q3 		$38K Buy
245
+83
+51% +$9.39K ﹤0.01% 2856
2019
Q2 		$12K Hold
162
– – ﹤0.01% 3328
2019
Q1 		$23K Buy
162
+14
+9% +$3.51K ﹤0.01% 3049
2018
Q4 		$60K Buy
148
+26
+21% +$12.2K ﹤0.01% 2630
2018
Q3 		$86K Buy
122
+40
+49% +$25.1K ﹤0.01% 2555
2018
Q2 		$44K Sell
82
-25
-23% -$7.69K ﹤0.01% 2805
2018
Q1 		$12K Buy
+107
New +$36.1K ﹤0.01% 3198

Other funds holding SLDB

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Legal & General Group's SLDB Position: Q2 2026 in Review

Legal & General Group increased its Solid Biosciences (SLDB) stake by 45% in Q2 2026, buying an estimated $18K and bringing the position to 7,639 shares worth $76.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2671.

Legal & General Group first reported a position in SLDB in Q1 2018 and has held it in 26 quarters since. The position peaked at $86K in Q3 2018. 157 funds tracked by Wall St. Rank hold SLDB as of Q2 2026.

  • Legal & General Group held 7,639 shares of Solid Biosciences worth $76.3K as of Q2 2026.
  • Legal & General Group bought 2,369 Solid Biosciences shares in Q2 2026, an estimated $18K.
  • Solid Biosciences made up ﹤0.01% of Legal & General Group's portfolio in Q2 2026, its #2671 holding.
  • Legal & General Group first reported a position in Solid Biosciences in Q1 2018 and has held it in 26 quarters since.
  • Legal & General Group's Solid Biosciences position peaked at $86K in Q3 2018.
  • 157 funds tracked by Wall St. Rank held Solid Biosciences as of Q2 2026.

Based on Legal & General Group's 13F filing for Q2 2026, filed 14 Aug 2026.